- Home
- PRVA vs MIR Comparison
PRVA vs MIR Comparison
Compare PRVA & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRVA
- MIR
- Stock Information
- Founded
- PRVA 2007
- MIR 2005
- Country
- PRVA United States
- MIR United States
- Employees
- PRVA N/A
- MIR N/A
- Industry
- PRVA Retail: Computer Software & Peripheral Equipment
- MIR Industrial Machinery/Components
- Sector
- PRVA Technology
- MIR Technology
- Exchange
- PRVA Nasdaq
- MIR Nasdaq
- Market Cap
- PRVA 2.8B
- MIR 3.1B
- IPO Year
- PRVA 2021
- MIR N/A
- Fundamental
- Price
- PRVA $25.02
- MIR $16.38
- Analyst Decision
- PRVA Strong Buy
- MIR Strong Buy
- Analyst Count
- PRVA 14
- MIR 4
- Target Price
- PRVA $27.57
- MIR $18.75
- AVG Volume (30 Days)
- PRVA 629.4K
- MIR 1.5M
- Earning Date
- PRVA 05-08-2025
- MIR 04-29-2025
- Dividend Yield
- PRVA N/A
- MIR N/A
- EPS Growth
- PRVA N/A
- MIR N/A
- EPS
- PRVA 0.12
- MIR N/A
- Revenue
- PRVA $1,801,244,000.00
- MIR $870,200,000.00
- Revenue This Year
- PRVA $88.96
- MIR $6.09
- Revenue Next Year
- PRVA $10.70
- MIR $7.37
- P/E Ratio
- PRVA $212.75
- MIR N/A
- Revenue Growth
- PRVA 6.79
- MIR 7.25
- 52 Week Low
- PRVA $15.92
- MIR $9.11
- 52 Week High
- PRVA $26.04
- MIR $18.81
- Technical
- Relative Strength Index (RSI)
- PRVA 63.91
- MIR 66.47
- Support Level
- PRVA $22.51
- MIR $15.55
- Resistance Level
- PRVA $26.09
- MIR $16.50
- Average True Range (ATR)
- PRVA 0.72
- MIR 0.54
- MACD
- PRVA 0.18
- MIR 0.17
- Stochastic Oscillator
- PRVA 70.11
- MIR 95.85
About PRVA Privia Health Group Inc.
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
About MIR Mirion Technologies Inc.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.